Hepatology
Latest News
MASLD linked to increased risk for various clinical outcomes
The disease significantly raises the risk for cardiovascular, metabolic, oncologic, and other outcomes.
Latest News
Early-onset NAFLD tied to higher cancer risk
Among adults younger than 45 at NAFLD onset, cancers were mainly digestive and lung cancers.
Latest News
No need to restrict hep C DAA therapy based on alcohol use
Alcohol use is not associated with decreased odds of a sustained virologic response to direct-acting antiviral therapy.
Latest News
Primary care clinicians should spearhead HIV prevention
U.S. Preventive Services Task Force guidelines call for clinicians to prescribe pre-exposure prophylaxis drugs to adolescents and adults who do...
Latest News
NAFLD raises risk for colorectal adenomatous polyps
In the fully adjusted model, NAFLD was a significant independent risk factor for adenomatous polyps but not for nonadenomatous polyps.
Latest News
New consensus on managing acetaminophen poisoning
The panel emphasized the role of the patient’s history; an inaccurate estimate of the time of ingestion can lead to the erroneous conclusion that...
Latest News
A decade after first DAA, only one in three are HCV free
Patients face barriers to being cured at every step of the way, from being diagnosed to accessing breakthrough DAA agents.
Latest News
GLP-1 agonists offer multiple benefits in type 2 diabetes with liver cirrhosis
“GLP-1 RAs may be a treatment option for diabetes patients with liver cirrhosis,” but additional studies are needed to confirm the results, the...
Latest News
SAFE algorithm detects liver disease in general population
Scoring system was developed and validated to detect clinically significant (greater than stage 2) fibrosis in patients with NAFLD in primary care...
Latest News
‘Exciting time for NASH’ with resmetirom phase 3 results
Two doses of resmetirom met the primary endpoints of NASH resolution and no worsening of fibrosis on liver biopsy.
Latest News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.